MIF-1 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
MIF-1 is administered via subcutaneous injection (poorly active orally) at 1-10 mg once daily. Subcutaneous injections into the abdominal fat or thigh are most common. Proper reconstitution with bacteriostatic water is required first.
How Do You Inject MIF-1?
MIF-1 is administered via subcutaneous injection (poorly active orally). For most researchers, subcutaneous injection is the standard approach — it's simple, relatively painless, and effective for Neuropeptide, dopamine receptor modulator compounds.
This guide covers injection technique, site selection, needle choices, and common mistakes.
How Do You Prepare for a MIF-1 Injection?
Step 1: Wash your hands thoroughly.
Step 2: Clean the top of the MIF-1 vial and BAC water vial with alcohol swabs. If not yet reconstituted, see our MIF-1 reconstitution guide.
Step 3: Draw your dose (1-10 mg) into an insulin syringe. Use our calculator for exact units.
Step 4: Clean the injection site with an alcohol swab and let it dry.
What Is the Correct Injection Technique?
Subcutaneous (most common): Pinch a fold of skin — typically abdominal fat 2+ inches from the navel, or the thigh. Insert the needle at a 45-degree angle. Push the plunger slowly and steadily. Hold for 5 seconds, then withdraw.
Intramuscular (less common for MIF-1): Insert the needle at 90 degrees into the muscle (deltoid or vastus lateralis). This route provides faster absorption but isn't necessary for most peptide protocols.
Rotate injection sites to prevent lipodystrophy (fat tissue changes from repeated injections in the same spot).
What Size Needle Should You Use?
For subcutaneous MIF-1 injections, 29-31 gauge insulin needles (½ inch or 8mm) are standard. These are thin enough to be nearly painless while long enough for proper subcutaneous delivery.
Use a fresh needle for every injection. Never reuse or share needles.
Calculate Your MIF-1 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for MIF-1.
Open Calculator →What Are Common Injection Side Effects?
Mild redness, swelling, or itching at the injection site is normal and typically resolves within hours. Small bruises can occur, especially if you hit a capillary.
If you experience persistent pain, swelling, warmth, or redness lasting more than 24 hours, discontinue and consult a healthcare provider — these may indicate infection.
Bottom Line on MIF-1 Injection
MIF-1 is administered via subcutaneous injection (poorly active orally) at 1-10 mg once daily. Subcutaneous injection with a 29-31 gauge insulin needle into abdominal fat is the standard technique. Rotate sites and use a fresh needle every time.
Complete Guide
MIF-1 : Benefits, Dosage, Side Effects & Research
Related Reading
- MIF-1 Dosage Guide
- MIF-1 Benefits
- MIF-1 Side Effects
- MIF-1 Stacking Guide
- MIF-1 Cycle Guide
- MIF-1 Research
Research-Grade Sourcing
If you're going to research MIF-1, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is MIF-1?
MIF-1 (Pro-Leu-Gly-NH2 (Melanocyte-inhibiting factor-1)) is a Neuropeptide, dopamine receptor modulator. Endogenous tripeptide derived from cleavage of oxytocin, produced primarily by the hypothalamus. It is researched for antidepressant effects, nootropic enhancement, anti-Parkinsonian action, dopamine modulation.
What is the recommended MIF-1 dosage?
Common dosages: 1-10 mg administered once daily via subcutaneous injection (poorly active orally). Cycle length: not established; short protocols in research. Half-life: resistant to bloodstream metabolism; crosses blood-brain barrier. Use our peptide calculator for exact reconstitution math.
What are the side effects of MIF-1?
Limited human data. Inverted U-curve response — loses efficacy at very high doses. No serious adverse effects documented.
Is MIF-1 safe?
MIF-1 has shown a preliminary safety profile in research. Not FDA-approved. Research chemical. All research should follow appropriate safety protocols.